3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
1397
Neoplasms
1129
Prostatic Neoplasms
744
Lung Neoplasms
619
Colorectal Neoplasms
596
Carcinoma, Non-Small-Cell Lung
569
Carcinoma, Hepatocellular
413
Pancreatic Neoplasms
402
Leukemia, Myeloid, Acute
398
Stomach Neoplasms
355
Multiple Myeloma
326
Brain Neoplasms
311
Ovarian Neoplasms
309
Head and Neck Neoplasms
289
Neoplasm Metastasis
273
Precursor Cell Lymphoblastic Leukemia-Lymphoma
260
Rectal Neoplasms
253
Uterine Cervical Neoplasms
248
Recurrence
248
Melanoma
242
Esophageal Neoplasms
237
Glioblastoma
232
Squamous Cell Carcinoma of Head and Neck
231
Lymphoma
213
Sarcoma
207
Urinary Bladder Neoplasms
192
Colonic Neoplasms
192
Glioma
191
Triple Negative Breast Neoplasms
188
Hematologic Neoplasms
183
Interventions
palbociclib
1
exemestane
1
elacestrant
1
Tamoxifen
1
Letrozole
1
Fulvestrant
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
ER+ Breast Cancer
×
Clear all
NCT06923527
2026-05-12
Circulating Tumor DNA
Yale University
Phase 2
Recruiting
50 enrolled
NCT04985266
2024-12-05
TRAK-ER
Royal Marsden NHS Foundation Trust
Phase 2
Recruiting
1,100 enrolled